|Articles|November 1, 2001
Glaucoma Drug Comparison Shows IOP-Lowering Effect
Memphis, TN-Travoprost ophthalmic solution (Travatan, Alcon) has been shown to be equal or superior to latanoprost (Xalatan, Pharmacia) and superior to timolol in lowering IOP in patients with open-angle glaucoma or ocular hypertension, according to a recent study.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
AI in ophthalmology research: Ethical implications for medical students
2
How AI is reshaping ophthalmology in 2025 and beyond
3
From bench to bedside: Evolving realities of gene therapy for inherited retinal diseases
4
Reimagining dry eye care: Focus on sustained tear production
5





































